Strasbourg, France

Guy Vincendon

This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guy Vincendon: Innovator in Neurology Diagnostics

Introduction

Guy Vincendon is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of neurology, particularly in the diagnosis of demyelinating neuropathies. His work is essential for advancing medical understanding and treatment options for conditions such as multiple sclerosis.

Latest Patents

Guy Vincendon holds a patent for "Agents for the diagnosis of demyelinating neuropathies." This invention focuses on the use of endogenous lectins that have an affinity for glycans rich in mannose. These lectins or their protein subunits are immunologically related to cerebellar soluble lectins, which play a crucial role in diagnosing conditions like multiple sclerosis.

Career Highlights

Vincendon is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work there has allowed him to explore innovative diagnostic methods that can significantly impact patient care in neurology.

Collaborations

Throughout his career, Guy Vincendon has collaborated with esteemed colleagues such as Jean-Pierre Zanetta and Jean-Marie Warter. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Guy Vincendon is a prominent figure in the realm of neurology diagnostics, with a focus on innovative methods for diagnosing demyelinating neuropathies. His contributions are vital for improving medical practices and patient outcomes in neurology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…